United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE339.1200
- TODAY'S CHANGE (%)-1.9900 (-0.5834%)
- Bid / Lots335.7000/ 1
- Ask / Lots350.3800/ 2
- Open / Previous Close341.6900 / 341.1100
- Day Range
- 52 Week Range
- Volume455,672
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 2012 | 341.69 |
| 09:39 ET | 300 | 343.62 |
| 09:41 ET | 639 | 345.59 |
| 09:43 ET | 200 | 345.58 |
| 09:45 ET | 600 | 345.72 |
| 09:48 ET | 401 | 346.355 |
| 09:50 ET | 2000 | 346.75 |
| 09:52 ET | 1295 | 346.06 |
| 09:54 ET | 400 | 345.75 |
| 09:59 ET | 889 | 344.98 |
| 10:01 ET | 600 | 345.86 |
| 10:08 ET | 1522 | 343.46 |
| 10:10 ET | 100 | 343.54 |
| 10:12 ET | 1102 | 343.685 |
| 10:15 ET | 700 | 343.91 |
| 10:17 ET | 100 | 344.25 |
| 10:19 ET | 100 | 344.365 |
| 10:24 ET | 100 | 344.23 |
| 10:26 ET | 100 | 343.92 |
| 10:30 ET | 817 | 343.455 |
| 10:33 ET | 100 | 343.41 |
| 10:35 ET | 205 | 343.24 |
| 10:37 ET | 1427 | 343.19 |
| 10:39 ET | 1020 | 343.665 |
| 10:42 ET | 200 | 343.635 |
| 10:44 ET | 295 | 343.524 |
| 10:48 ET | 900 | 342.65 |
| 10:55 ET | 400 | 342.08 |
| 10:57 ET | 100 | 341.73 |
| 11:00 ET | 200 | 341.5 |
| 11:02 ET | 653 | 341.945 |
| 11:04 ET | 400 | 342.31 |
| 11:08 ET | 1291 | 342.05 |
| 11:09 ET | 1550 | 342.07 |
| 11:11 ET | 100 | 342.05 |
| 11:13 ET | 100 | 342.05 |
| 11:15 ET | 500 | 341.61 |
| 11:18 ET | 300 | 341.72 |
| 11:20 ET | 900 | 340.79 |
| 11:26 ET | 700 | 341.28 |
| 11:36 ET | 704 | 341.06 |
| 11:38 ET | 1424 | 340.77 |
| 11:40 ET | 300 | 340.44 |
| 11:42 ET | 600 | 340.81 |
| 11:44 ET | 1743 | 341.18 |
| 11:45 ET | 620 | 341.27 |
| 11:47 ET | 125 | 341.23 |
| 11:49 ET | 225 | 341.455 |
| 11:51 ET | 440 | 341.5 |
| 11:54 ET | 825 | 341.61 |
| 11:56 ET | 200 | 341.35 |
| 11:58 ET | 2323 | 341.86 |
| 12:02 ET | 2500 | 341.03 |
| 12:07 ET | 200 | 340.7 |
| 12:09 ET | 4703 | 340.58 |
| 12:12 ET | 100 | 340.26 |
| 12:14 ET | 842 | 340.595 |
| 12:18 ET | 200 | 340.6 |
| 12:21 ET | 300 | 340.54 |
| 12:23 ET | 200 | 340.555 |
| 12:25 ET | 100 | 340.555 |
| 12:27 ET | 1546 | 340.37 |
| 12:34 ET | 615 | 340.45 |
| 12:36 ET | 100 | 340.63 |
| 12:38 ET | 800 | 340.565 |
| 12:39 ET | 100 | 340.585 |
| 12:41 ET | 200 | 340.41 |
| 12:43 ET | 300 | 340.4 |
| 12:45 ET | 200 | 340.445 |
| 12:48 ET | 100 | 340.27 |
| 12:50 ET | 300 | 340.3 |
| 12:52 ET | 2819 | 340.35 |
| 12:56 ET | 1444 | 339.715 |
| 12:57 ET | 3409 | 339.675 |
| 01:01 ET | 200 | 339.35 |
| 01:03 ET | 200 | 339.31 |
| 01:06 ET | 1646 | 339.385 |
| 01:08 ET | 2180 | 339.3 |
| 01:10 ET | 200 | 339.19 |
| 01:12 ET | 100 | 339.19 |
| 01:14 ET | 200 | 339.46 |
| 01:15 ET | 3124 | 339.47 |
| 01:19 ET | 300 | 339.07 |
| 01:24 ET | 1248 | 338.59 |
| 01:26 ET | 1516 | 338.5 |
| 01:28 ET | 200 | 338.27 |
| 01:30 ET | 100 | 338.27 |
| 01:32 ET | 645 | 338.16 |
| 01:33 ET | 800 | 339.14 |
| 01:35 ET | 700 | 339.52 |
| 01:37 ET | 400 | 339.03 |
| 01:39 ET | 212 | 339.05 |
| 01:42 ET | 504 | 339 |
| 01:44 ET | 536 | 338.55 |
| 01:46 ET | 200 | 338.91 |
| 01:53 ET | 100 | 338.635 |
| 01:55 ET | 100 | 338.6 |
| 01:57 ET | 240 | 338.37 |
| 02:02 ET | 1184 | 337.52 |
| 02:04 ET | 1591 | 337.985 |
| 02:08 ET | 700 | 338.34 |
| 02:09 ET | 200 | 338.585 |
| 02:13 ET | 100 | 338.64 |
| 02:15 ET | 213 | 338.74 |
| 02:18 ET | 200 | 338.74 |
| 02:20 ET | 100 | 338.58 |
| 02:27 ET | 758 | 338.44 |
| 02:29 ET | 1407 | 338.345 |
| 02:31 ET | 1670 | 338.01 |
| 02:33 ET | 900 | 337.85 |
| 02:38 ET | 400 | 337.71 |
| 02:42 ET | 100 | 337.805 |
| 02:44 ET | 100 | 338.07 |
| 02:45 ET | 100 | 337.84 |
| 02:47 ET | 300 | 337.87 |
| 02:49 ET | 830 | 337.645 |
| 02:51 ET | 1653 | 338.075 |
| 02:54 ET | 100 | 337.73 |
| 02:56 ET | 244 | 337.91 |
| 02:58 ET | 400 | 338.26 |
| 03:00 ET | 1476 | 338.34 |
| 03:02 ET | 864 | 337.99 |
| 03:03 ET | 1104 | 337.65 |
| 03:05 ET | 1122 | 337.845 |
| 03:07 ET | 2127 | 337.905 |
| 03:09 ET | 1826 | 338.105 |
| 03:12 ET | 200 | 337.93 |
| 03:16 ET | 100 | 338.19 |
| 03:18 ET | 200 | 338.29 |
| 03:20 ET | 100 | 338.295 |
| 03:21 ET | 400 | 338.305 |
| 03:23 ET | 1600 | 337.98 |
| 03:27 ET | 3895 | 338.655 |
| 03:30 ET | 586 | 338.66 |
| 03:32 ET | 3489 | 339.155 |
| 03:34 ET | 362 | 339.025 |
| 03:36 ET | 684 | 338.97 |
| 03:38 ET | 1619 | 338.71 |
| 03:39 ET | 290 | 338.62 |
| 03:41 ET | 4613 | 338.53 |
| 03:43 ET | 6785 | 339.345 |
| 03:45 ET | 500 | 339 |
| 03:48 ET | 2050 | 339.285 |
| 03:50 ET | 1410 | 339.03 |
| 03:52 ET | 2490 | 338.975 |
| 03:54 ET | 2030 | 339.205 |
| 03:56 ET | 3286 | 338.1 |
| 03:57 ET | 2497 | 338.96 |
| 03:59 ET | 79038 | 339.12 |
Sep 10, 2024
Aug 28, 2024
DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 9:08AM ET on Wednesday Aug 28, 2024 by Dow Jones
9:08AM ET on Wednesday Aug 28, 2024 by Dow JonesUnited Therapeutics Corporation to Present at Upcoming Investor Conferences, from 7:00AM ET on Wednesday Aug 28, 2024 by Dow Jones
7:00AM ET on Wednesday Aug 28, 2024 by Dow Jones
Aug 20, 2024
DJ United Therapeutics Is Maintained at Overweight by Wells Fargo, from 12:31PM ET on Tuesday Aug 20, 2024 by Dow Jones
12:31PM ET on Tuesday Aug 20, 2024 by Dow Jones
Aug 19, 2024
DJ S&P 500 Futures Steady In Premarket Trading; United Therapeutics, Tempus AI Lead, from 7:30AM ET on Monday Aug 19, 2024 by Dow Jones
7:30AM ET on Monday Aug 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 15.1B | 15.6x | +8.22% |
Biomarin Pharmaceutical Inc | 16.2B | 64.0x | --- |
Exact Sciences Corp | 12.1B | -68.2x | --- |
Neurocrine Biosciences Inc | 12.3B | 36.9x | +62.04% |
Qiagen NV | 10.4B | 145.7x | +12.66% |
Medpace Holdings Inc | 10.9B | 33.1x | +35.10% |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.1B |
|---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.58 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 15.6x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | 13.4x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
